中医治疗血液病名家学术观点撷菁Ⅲ

Essential viewpoints of prestigious experts on TCM treatment of hematological diseases Ⅲ

为更好地总结与传承中医血液病学领域名中医学术思想及临床经验,中华中医药学会血液病分会、中华中医药学会血液病创新研究与转化平台已对周霭祥等15位中医与中西医结合专家的学术思想与临床经验进行了总结。本文由传承弟子对柯微君、戴锡孟、陈安民、麻柔、李建华、蒋红玉6位教授的临床诊疗经验与学术思想进行总结。其中,柯微君教授衷中参西治疗血液病,强调辨明邪正关系,掌握病证演变规律;戴锡孟教授治疗再生障碍性贫血(简称“再障”)以肾虚为核心确立治则,率先应用六神丸治疗白血病;陈安民教授提出血液病治疗的“四维生血”“六合共治”理论;麻柔教授采用中西医结合辨治血液病,率先应用青黄散治疗骨髓增生异常综合征;李建华教授提出再障“酶损伤在先的发病机制”新假说,构建了较为成熟的中西医结合诊疗模式;蒋红玉教授提出再障中医辨病论治、辨证论治、辨兼证论治相结合的“三辨论治”及防发变复三级预防治疗新模式。本研究的目的是建立中医药治疗血液系统疾病专家经验传承与创新的共荣体,进一步丰富与完善传承与创新体系,培养和提高中医血液病学后备人才的综合诊治能力和水平。

In order to summarize the academic thoughts and clinical experience of prestigious traditional Chinese medicine(TCM)hematological experts,China Association of Chinese Medicine Blood Disease Branch and the Hematological Diseases'Innovative Research and Transformation Platform of China Association of Chinese Medicine have summarized the academic thoughts and clinical experience of 15 TCM and integrated TCM and western medicine experts such as ZHOU Aixiang.Investigators summarized the clinical diagnosis and treatment experience and academic thoughts of Professors KE Weijun,DAI Ximeng,CHEN Anmin,MA Rou,LI Jianhua,and JIANG Hongyu.Among them,Professor KE Weijun treats hematological diseases with TCM and western medicine and emphasizes the relationship between healthy qi and pathogenic qi based on the evolution rule of disease and syndrome.Professor DAI Ximeng establishes the treatment principle with kidney deficiency as the core in the treatment of aplastic anemia,and takes the lead in the application of Liushen Pill in the treatment of leukemia.Professor CHEN Anmin puts forward the theory of"four-dimensional blood production"and"six-in-one co-treatment"in the treatment of hematological diseases.Professor MA Rou adopts a combination of TCM and western medicine to treat hematological diseases based on syndrome differentiation,and is the first to apply Qinghuang Powder to treat myelodysplastic syndrome.Professor LI Jianhua puts forward a new hypothesis of"the pathogenesis of enzyme injury first"in aplastic anemia,and constructs a more mature diagnosis and treatment model of integrated TCM and western medicine.Professor JIANG Hongyu proposes a new model of treating aplastic anemia in Chinese medicine,which is a combination of disease,syndrome,and concurrent differentiation and treatment,"triple diagnosis and treatment",and tertiary prevention of morbidity and recurrence.The purpose of this initiative is to create a co-prosperity body to summarize and build on the experience of experts in TCM for the treatment of hematological disorders,to further enrich and improve the system of inheritance and innovation,and to cultivate and improve the diagnosis and treatment of hematological diseases.